Table 2 DLS analysis of miR34a-Cis-Lip-RGD over a 3-week storage period at 4 °C
From: Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mir-34a and cisplatin
Time (week) | Size (nm) + SD |
|---|---|
0 | 213.9 ± 12.3 |
1 | 216.1 ± 13 |
2 | 218.5 ± 13.3 |
3 | 235.7 ± 28.7 |